TFDP2
Basic information
Region (hg38): 3:141944428-142149544
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TFDP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 16 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 17 | 0 | 0 |
Variants in TFDP2
This is a list of pathogenic ClinVar variants found in the TFDP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-141952562-T-C | not specified | Uncertain significance (Sep 12, 2023) | ||
3-141952577-G-T | not specified | Uncertain significance (Jan 23, 2024) | ||
3-141952675-C-A | not specified | Uncertain significance (Apr 13, 2022) | ||
3-141952695-C-T | not specified | Uncertain significance (Jul 07, 2022) | ||
3-141952936-T-C | not specified | Uncertain significance (Feb 14, 2024) | ||
3-141959685-C-A | not specified | Uncertain significance (Mar 19, 2024) | ||
3-141959775-C-T | not specified | Uncertain significance (Jun 06, 2023) | ||
3-141959776-G-A | not specified | Uncertain significance (Apr 07, 2023) | ||
3-141963899-G-T | not specified | Uncertain significance (Apr 26, 2023) | ||
3-141963957-C-T | not specified | Uncertain significance (Dec 15, 2023) | ||
3-141970128-C-T | not specified | Uncertain significance (Oct 16, 2023) | ||
3-141974065-C-G | not specified | Uncertain significance (Apr 01, 2024) | ||
3-141978543-T-C | not specified | Uncertain significance (Nov 18, 2023) | ||
3-141978663-C-T | not specified | Uncertain significance (Nov 19, 2022) | ||
3-141978677-C-T | not specified | Uncertain significance (Dec 12, 2023) | ||
3-142005454-A-G | not specified | Uncertain significance (Jun 29, 2022) | ||
3-142005491-T-C | not specified | Uncertain significance (May 23, 2023) | ||
3-142005508-G-A | not specified | Uncertain significance (Jul 25, 2023) | ||
3-142005541-T-C | not specified | Uncertain significance (Mar 24, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TFDP2 | protein_coding | protein_coding | ENST00000489671 | 12 | 205110 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000502 | 121764 | 0 | 2 | 121766 | 0.00000821 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.69 | 156 | 228 | 0.685 | 0.0000113 | 2893 |
Missense in Polyphen | 44 | 79.533 | 0.55323 | 1038 | ||
Synonymous | 1.38 | 72 | 88.5 | 0.814 | 0.00000469 | 857 |
Loss of Function | 4.57 | 1 | 26.3 | 0.0381 | 0.00000154 | 297 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000583 | 0.0000567 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000975 | 0.00000894 |
Middle Eastern | 0.0000583 | 0.0000567 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Can stimulate E2F-dependent transcription. Binds DNA cooperatively with E2F family members through the E2 recognition site, 5'-TTTC[CG]CGC-3', found in the promoter region of a number of genes whose products are involved in cell cycle regulation or in DNA replication. The TFDP2:E2F complex functions in the control of cell-cycle progression from G1 to S phase. The E2F1:DP complex appears to mediate both cell proliferation and apoptosis. Blocks adipocyte differentiation by repressing CEBPA binding to its target gene promoters (PubMed:20176812). {ECO:0000305|PubMed:20176812}.;
- Pathway
- Cell cycle - Homo sapiens (human);Retinoblastoma (RB) in Cancer;G1 to S cell cycle control;Signal Transduction;Gene expression (Transcription);Inhibition of replication initiation of damaged DNA by RB1/E2F1;Transcriptional Regulation by E2F6;Generic Transcription Pathway;Oncogene Induced Senescence;Oxidative Stress Induced Senescence;Cellular Senescence;Cellular responses to stress;RNA Polymerase II Transcription;Activation of NOXA and translocation to mitochondria;Activation of PUMA and translocation to mitochondria;Activation of BH3-only proteins;Intrinsic Pathway for Apoptosis;Transcription of E2F targets under negative control by DREAM complex;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;G0 and Early G1;Apoptosis;Programmed Cell Death;Cyclin D associated events in G1;G1 Phase;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Activation of E2F1 target genes at G1/S;G1/S-Specific Transcription;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;E2F mediated regulation of DNA replication;Mitotic G1-G1/S phases;Signaling by NOTCH;Cellular responses to external stimuli;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;TGF_beta_Receptor;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;TP53 Regulates Transcription of Cell Cycle Genes;G1/S Transition;Transcriptional Regulation by TP53;Cell Cycle;Signaling by TGF-beta Receptor Complex;Signaling by TGF-beta family members;Cell Cycle, Mitotic;E2F transcription factor network
(Consensus)
Recessive Scores
- pRec
- 0.182
Intolerance Scores
- loftool
- 0.483
- rvis_EVS
- -0.14
- rvis_percentile_EVS
- 43.29
Haploinsufficiency Scores
- pHI
- 0.963
- hipred
- N
- hipred_score
- 0.481
- ghis
- 0.581
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.683
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tfdp2
- Phenotype
Gene ontology
- Biological process
- regulation of transcription involved in G1/S transition of mitotic cell cycle;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;heart development;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;negative regulation of G0 to G1 transition;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway
- Cellular component
- nucleus;nucleoplasm;mitochondrion;RNA polymerase II transcription factor complex
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;transcription coregulator activity;protein binding;transcription factor binding;protein domain specific binding